🇺🇸 FDA

Drug profile · INN

torsemide

TORSEMIDE

approved
US status
approved
Patents linked
4
News articles
0

Quick answer

torsemide (TORSEMIDE) is an FDA-listed pharmaceutical active ingredient. Associated with Regeneron Ireland Designated Activity Company (DAC). Route of administration: oral. Current US regulatory status: approved.

Key facts

INN torsemide
Brand TORSEMIDE
Route ORAL
Formulation SOLUTION
Originator Regeneron Ireland Designated Activity Company (DAC)

Related patents

Search patents →

  1. US 6670478

    Process for preparing torsemide intermediate

    Expires Mon Dec 25 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  2. US 6635765

    Processes for preparing torsemide intermediate

    Expires Mon Oct 16 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  3. US 6482417

    Stable pharmaceutical formulation comprising torsemide modification II

    Expires Mon Nov 14 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  4. US 6465496

    Torsemide polymorphs

    Expires Mon Oct 10 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

Frequently asked questions

What is torsemide?

torsemide (TORSEMIDE) is an FDA-listed pharmaceutical active ingredient. Associated with Regeneron Ireland Designated Activity Company (DAC). Route of administration: oral. Current US regulatory status: approved.

What is the brand name for torsemide?

TORSEMIDE is a marketed brand name for torsemide. Check FDA Drugs@FDA for the current US label holder and prescribing information.

What is the US approval status of torsemide?

torsemide has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.